USFDA lifts import alert imposed on Aurobindo Pharma’s Unit-VI in Hyderabad

28 Mar 2013 Evaluate

USFDA has lifted the import alert for non-sterile products manufactured in Aurobindo Pharma‘s Unit-VI cephalosporin facility based in Hyderabad, India, thereby paving the way for resumption of exports of 9 products to the US market. The import alert was imposed earlier in February 2011. Prior to import alert, the Unit was having annual US sales of $ 33 million for the products.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.

Aurobindo Pharma Share Price

1198.50 -8.30 (-0.69%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×